Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak

Ren, Zhenxiao, Nishimura, Nishimura, Tjan, Lidya Handayani, Furukawa, Koichi, Kurahashi, Yukiya, Sutandhio, Silvia, Aoki, Kaito, Hasegawa, Natsumi, Arii, Jun, Uto, Kenichi, Matsui, Keiji, Sato, Itsuko, Saegusa, Jun, Godai, Nonoka, Takeshita, Kohei, Yamamoto, Masaki, Nagashima, Tatsuya and MoriI, Yasuko (2022) Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak. PLOS ONE, 17 (4). pp. 1-16. ISSN 19326203

[thumbnail of Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak]
Preview
Text (Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak)
5-Large_scale_serosurveillance_.pdf

Download (2MB) | Preview

Abstract

Continuous appearance of SARS-CoV-2 variants and mass vaccination have been intricately influencing on the COVID-19 situation. To elucidate the current status in Japan, we analyzed totally 2,000 sera in August (n = 1,000) and December (n = 1,000) 2021 collected from individuals who underwent a health check-up. The anti-N seropositive rate were 2.1% and 3.9% in August and December 2021, respectively, demonstrating a Delta variant endemic during that time; it was approximately twofold higher than the rate based on the PCR-based diagnosis. The anti-S seropositive rate was 38.7% in August and it reached 90.8% in December, in concordance with the vaccination rate in Japan. In the December cohort, 78.7% of the sera showed neutralizing activity against the Delta variant, whereas that against the Omicron was much lower at 36.6%. These analyses revealed that effective immunity against the Delta variant was established in December 2021, however, prompt three-dose vaccination is needed to overcome Omicron’s outbreak.

Item Type: Article
Subjects: Medicine
Divisions: Journal Publication
Depositing User: F.X. Hadi
Date Deposited: 24 Jul 2025 02:44
Last Modified: 24 Jul 2025 02:44
URI: https://repositori.ukwms.ac.id/id/eprint/44202

Actions (login required)

View Item View Item